Cleared Traditional

K261225 - CAS-One IR

K261225 is an FDA 510(k) clearance for CAS-One IR, manufactured by Cascination AG. The device is a Class 2 Radiology device with product code JAK cleared through the Traditional 510(k) pathway after a 167-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2026
Decision
167d
Days
Class 2
Risk

K261225 is an FDA 510(k) clearance for the CAS-One IR. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Cascination AG (Bern, CH). The FDA issued a Cleared decision on September 29, 2026 after a review of 167 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Cascination AG devices

FDA 510(k) Submission Details - K261225

510(k) Number K261225 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 15, 2026
Decision Date September 29, 2026
Days to Decision 167 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
60d slower than avg
Panel avg: 107d · This submission: 167d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JAK Device Classification - Class 2, Special Controls

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 757
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K261225.
BodyTom 64 (NL4100)
K261125 · Samsung HME America, Inc., dba NeuroLogica Corp. · Sep 2026
SCENARIA View Phase 6.0
K261229 · Fujifilm Corporation · Sep 2026
FCT iStream Phase 2
K253836 · Fujifilm Corporation · Sep 2026
BodyTom Elite (NL4000)
K253450 · NeuroLogica Corp., a Samsung Company · Jul 2026
CardIQ Suite
K253770 · GE Medical Systems SCS · Jul 2026
Enhanced Boundary for PCCT
K253560 · Ge Medical Systems, LLC · Jun 2026